Could a weight-loss procedure do more than just shed pounds? New research suggests bariatric surgery slashes the risk of pancreatic cancer by up to 79% for people with type 2 diabetes—and by 54% overall.
A sweeping meta-analysis of over 3.7 million adults found that those who underwent bariatric surgery were significantly less likely to develop one of the deadliest cancers. Surprisingly, sleeve gastrectomy showed a stronger protective effect than gastric bypass. But why?
Scientists believe the surgery’s metabolic changes—not just weight loss—may play a crucial role. Could this procedure be an untapped weapon against cancer?
While experts warn bariatric surgery shouldn’t be used solely for cancer prevention, the findings add another compelling reason to consider it for those at risk.